Suppr超能文献

[默克尔细胞癌:一种高度恶性的前B细胞/原B细胞肿瘤的皮肤表现?:关于默克尔细胞癌细胞起源的新概念]

[Merkel cell carcinoma: cutaneous manifestation of a highly malignant pre-/pro-B cell neoplasia? : Novel concept about the cellular origin of Merkel cell carcinoma].

作者信息

Sauer C M, Chteinberg E, Rennspiess D, Kurz A K, Zur Hausen A

机构信息

Department of Pathology, GROW-School for Oncology & Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, Netherlands.

Department of Internal Medicine IV, University Hospital Aachen, Aachen, Deutschland.

出版信息

Hautarzt. 2017 Mar;68(3):204-210. doi: 10.1007/s00105-017-3945-0.

Abstract

Merkel cell carcinoma (MCC) is a relatively rare but highly malignant non-melanoma skin cancer of the elderly and immunosuppressed patients. The discovery of the Merkel cell polyomavirus (MCPyV) in 2008 significantly impacted the understanding of the etiopathogenesis of MCC. MCPyV is clonally integrated into the MCC genome and approximately 80% of MCC are MCPyV-positive. Recent results of clinical trials using blockade of the PD-1 immune modulatory pathway are promising for the future treatment of MCC. Despite this major progress of the past few years, the cellular origin of MCC still remains obscure. Based on histomorphology, gene expression profiling, and molecular analyses, we have recently hypothesized that MCC originates from pre‑/pro-B cells. Here we review putative cells of MCC, including Merkel cells, (epi‑)dermal stem cells, and pro‑/pre-B cells. In the present work, the focus is on the concept of pre‑/pro-B cells as the cellular origin of MCC, which might also impact the understanding of other human small cell malignancies of unknown cellular origin, such as small cell carcinomas of the lung and other anatomical locations. In addition, this concept might pave the way for novel treatment options, especially for advanced MCC.

摘要

默克尔细胞癌(MCC)是一种相对罕见但高度恶性的非黑色素瘤皮肤癌,好发于老年人及免疫抑制患者。2008年默克尔细胞多瘤病毒(MCPyV)的发现极大地影响了对MCC病因发病机制的理解。MCPyV克隆性整合到MCC基因组中,约80%的MCC为MCPyV阳性。近期使用PD-1免疫调节通路阻断剂的临床试验结果为MCC的未来治疗带来了希望。尽管在过去几年取得了这一重大进展,但MCC的细胞起源仍然不明。基于组织形态学、基因表达谱分析和分子分析,我们最近推测MCC起源于前B/前体B细胞。在此,我们综述了MCC的假定细胞,包括默克尔细胞、(表皮)真皮干细胞和前体B/前B细胞。在本研究中,重点是前体B/前B细胞作为MCC细胞起源的概念,这也可能影响对其他细胞起源不明的人类小细胞恶性肿瘤的理解,如肺癌和其他解剖部位的小细胞癌。此外,这一概念可能为新的治疗选择铺平道路,尤其是对于晚期MCC。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验